There is significant improvement in blood glucose, plasma insulin, glucose tolerance, β cell proliferation, and β cell mass, resulting in the reversal of diabetes in OPG-treated versus control saline- or immunoglobulin G (IgG)–treated diabetic NOD mice. The gene discussed is TNFRSF11B; the disease is diabetes mellitus.